Evidence map›Paper›PMID 30419932›Full record

ArticleBMC medical genetics2018

Expanding the clinical phenotype of IARS2-related mitochondrial disease.

Barbara Vona, Reza Maroofian, Emanuele Bellacchio, Maryam Najafi, Kyle Thompson, Ahmad Alahmad, Langping He, Najmeh Ahangari, Abolfazl Rad, Sima Shahrokhzadeh and 13 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Candidate Genes for Non-Syndromic Pediatric Cataracts.Clinical ophthalmology (Auckland, N.Z.) · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Adrenal Dysfunction in Mitochondrial Diseases.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Frontiers in pediatrics · 2022
    Article
  13. BiallelicHaematologica · 2021
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 5 countries.

Barbara VonaInstitute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany. barbara.vona@uni-wuerzburg.de.ORCID 0000-0002-6719-3447
Reza MaroofianGenetics and Molecular Cell Sciences Research Centre, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK.
Emanuele BellacchioGenetics and Rare Diseases, Research Division, 'Bambino Gesù' Children Hospital, Rome, Italy.
Maryam NajafiGenome Research Division, Human Genetics Department, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, 6525KL, Nijmegen, The Netherlands.
Kyle ThompsonWellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Ahmad AlahmadWellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Langping HeWellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Najmeh AhangariFaculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abolfazl RadGenome Research Division, Human Genetics Department, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, 6525KL, Nijmegen, The Netherlands.
Sima ShahrokhzadehNext Generation Genetic Clinic, Mashhad, Iran.
Paulina BahenaInstitute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany.
Falk MittagDepartment of Orthopaedic Surgery, University Hospital of Tübingen, Hoppe-Seyler-Strasse 3, 72076, Tübingen, Germany.
Frank TraubDepartment of Orthopaedic Surgery, University Hospital of Tübingen, Hoppe-Seyler-Strasse 3, 72076, Tübingen, Germany.
Jebrail MovaffaghTargeted Drug Delivery Research Center, Pharmaceutical Technology Institute, University of Medical Sciences, Mashhad, Iran.
Nafise AmiriTargeted Drug Delivery Research Center, Pharmaceutical Technology Institute, University of Medical Sciences, Mashhad, Iran.
Mohammad DoostiNext Generation Genetic Clinic, Mashhad, Iran.
Reza BoostaniDepartment of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ebrahim ShirzadehSabzevar University of Medical Sciences, Sabzevar, Iran.
Thomas HaafInstitute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany.
Daria DiodatoUnit of Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, 'Bambino Gesu' Children's Research Hospital, Rome, Italy.
Miriam SchmidtsGenome Research Division, Human Genetics Department, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 10, 6525KL, Nijmegen, The Netherlands.
Robert W TaylorWellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Ehsan Ghayoor KarimianiGenetics and Molecular Cell Sciences Research Centre, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. eghayoor@gmail.com.
Mashhad University of Medical Sciences · IRWellcome Centre for Mitochondrial Research · GBRadboud University Nijmegen · NLUniversity of Würzburg · DEBambino Gesù Children's Hospital · ITSabzevar University of Medical Sciences · IRSt George's, University of London · GB

Funding

Medical Research Council G0601943MRC Centre for Neuromuscular Diseases G0601943Wellcome TrustWellcome Trust 203105/Z/16/Z
6 · The paper itself

Abstract

backgroundIARS2 encodes a mitochondrial isoleucyl-tRNA synthetase, a highly conserved nuclear-encoded enzyme required for the charging of tRNAs with their cognate amino acid for translation. Recently, pathogenic IARS2 variants have been identified in a number of patients presenting broad clinical phenotypes with autosomal recessive inheritance. These phenotypes range from Leigh and West syndrome to a new syndrome abbreviated CAGSSS that is characterised by cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, as well as cataract with no additional anomalies.

methodsGenomic DNA from Iranian probands from two families with consanguineous parental background and overlapping CAGSSS features were subjected to exome sequencing and bioinformatics analysis.

resultsExome sequencing and data analysis revealed a novel homozygous missense variant (c.2625C > T, p.Pro909Ser, NM_018060.3) within a 14.3 Mb run of homozygosity in proband 1 and a novel homozygous missense variant (c.2282A > G, p.His761Arg) residing in an ~ 8 Mb region of homozygosity in a proband of the second family. Patient-derived fibroblasts from proband 1 showed normal respiratory chain enzyme activity, as well as unchanged oxidative phosphorylation protein subunits and IARS2 levels. Homology modelling of the known and novel amino acid residue substitutions in IARS2 provided insight into the possible consequence of these variants on function and structure of the protein.

conclusionsThis study further expands the phenotypic spectrum of IARS2 pathogenic variants to include two patients (patients 2 and 3) with cataract and skeletal dysplasia and no other features of CAGSSS to the possible presentation of the defects in IARS2. Additionally, this study suggests that adult patients with CAGSSS may manifest central adrenal insufficiency and type II esophageal achalasia and proposes that a variable sensorineural hearing loss onset, proportionate short stature, polyneuropathy, and mild dysmorphic features are possible, as seen in patient 1. Our findings support that even though biallelic IARS2 pathogenic variants can result in a distinctive, clinically recognisable phenotype in humans, it can also show a wide range of clinical presentation from severe pediatric neurological disorders of Leigh and West syndrome to both non-syndromic cataract and cataract accompanied by skeletal dysplasia.

Indexed as

AdultAmino Acid SequenceBone Diseases, DevelopmentalCataractConsanguinityExome SequencingFemaleGene ExpressionHearing Loss, SensorineuralHereditary Sensory and Autonomic NeuropathiesHomozygoteHumansIsoleucine-tRNA LigaseLeigh DiseaseMaleMitochondrial DiseasesIsoleucine-tRNA LigaseProtein SubunitsAdrenal insufficiencyCAGSSSCataractsGrowth hormone deficiencyIARS2Sensorineural hearing lossSensory neuropathySkeletal dysplasiaType II esophageal achalasia

Identifiers

PMID30419932
PMCPMC6233262
OpenAlexW2900934508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.